Symptomtext
patient under 65 was accidentally administered the Fluzone HD Quadrivalent with no reported adverse event; Initial information received on 06-Oct-2022 regarding an unsolicited valid non-serious case from a pharmacist. This case involves a 61 years old female patient who was under 65 and accidentally administered the influenza quadrival A-B high dose HV vaccine [Fluzone High-Dose Quadrivalent] with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included elasomeran (Moderna COVID-19 vaccine) for COVID-19 immunisation. On 05-Oct-2022, the patient received suspect influenza quadrival A-B high dose HV vaccine at a dose of 0.7 ml total (lot UJ926AA, expiry date: 30-Jun-2023) via intramuscular route in the left deltoid for immunisation. On 05-Oct-2022 the patient under 65 was accidentally administered the fluzone hd quadrivalent with no reported adverse event (product administered to patient of inappropriate age, latency: same day). Action taken: Not applicable. Outcome: Unknown. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.